Bain Capital Life Sciences Investors, LLC Kymera Therapeutics, Inc. Transaction History

Bain Capital Life Sciences Investors, LLC

  • $489 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$47.8 - $66.66 $22.9 Million - $32 Million
-479,605 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$28.07 - $87.83 $7.02 Million - $22 Million
-250,001 Reduced 34.27%
479,605 $29.7 Million
Q3 2020

Nov 16, 2020
BUY
$26.1 - $33.28 $19 Million - $24.3 Million
729,606 New
729,606 $23.6 Million

Others Institutions Holding KYMR

# of Institutions
163
Shares Held
63.1M
Call Options Held
22.6K
Put Options Held
14.4K
View Full List

About Kymera Therapeutics, Inc.

KYMR Quotes by TradingView
  • Ticker KYMR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,705,800
  • Market Cap $2.65B
  • Description
  • Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...
More about KYMR
Track This Portfolio

Track Bain Capital Life Sciences Investors, LLC Portfolio

Follow Bain Capital Life Sciences Investors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bain Capital Life Sciences Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bain Capital Life Sciences Investors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email